Cargando…
miR-429 Suppresses Endometrial Cancer Progression and Drug Resistance via DDX53
(1) Background: To examine miR-429-meditated DEAD (Asp-Glu-Ala-Asp) box polypeptide 53 (DDX53) function in endometrial cancer (EC). (2) Methods: DDX53 and miR-429 levels were measured using quantitative real-time polymerase chain reaction and western blotting assays, cell invasion and migration usin...
Autores principales: | Lee, Kyung-Jun, Singh, Nitya, Bizuneh, Michael, Kim, Nam-Hyeok, Kim, Hyeong Su, Kim, Youngmi, Lee, Jae-Jun, Kim, Jung Han, Kim, Jiye, Jeong, Soo Young, Cho, Hye-Yon, Park, Sung Taek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532590/ https://www.ncbi.nlm.nih.gov/pubmed/37763070 http://dx.doi.org/10.3390/jpm13091302 |
Ejemplares similares
-
The Role of ROR1 in Chemoresistance and EMT in Endometrial Cancer Cells
por: Lee, Kyung-Jun, et al.
Publicado: (2023) -
DDX53 Promotes Cancer Stem Cell-Like Properties and Autophagy
por: Kim, Hyuna, et al.
Publicado: (2017) -
DDX53 Regulates Cancer Stem Cell-Like Properties by Binding to SOX-2
por: Kim, Youngmi, et al.
Publicado: (2017) -
Berberine inhibits the proliferation, invasion and migration of endometrial stromal cells by downregulating miR-429
por: Gu, Yongjuan, et al.
Publicado: (2021) -
miR-30a Regulates the Expression of CAGE and p53 and Regulates the Response to Anti-Cancer Drugs
por: Park, Deokbum, et al.
Publicado: (2016)